QUDEXY XR
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0245-1072 -
Package NDC
0245-1072-30 -
Package NDC
0245-1072-90 -
Application number
NDA205122 -
SPL ID
5cfd7234-5efc-4cb8-b69c-7e68b9f1a94f -
SPL set ID
46f54677-3a22-4c38-9b92-923020164e15 -
UNII
0H73WJJ391 -
RxCUI
1494766 -
RxCUI
1494769 -
RxCUI
1494771 -
RxCUI
1494775 -
RxCUI
1494778 -
RxCUI
1494781 -
RxCUI
1812419 -
RxCUI
1812421 -
RxCUI
1812425 -
RxCUI
1812427
What the source publishes
- Labeler
- Upsher-Smith Laboratories, LLC
- Active ingredients
- Topiramate
- Form
- CAPSULE, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "QUDEXY XR",
"splId": "5cfd7234-5efc-4cb8-b69c-7e68b9f1a94f",
"labels": [
{
"setId": "46f54677-3a22-4c38-9b92-923020164e15",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=46f54677-3a22-4c38-9b92-923020164e15",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=46f54677-3a22-4c38-9b92-923020164e15"
}
],
"routes": [
"ORAL"
],
"labeler": "Upsher-Smith Laboratories, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 BOTTLE in 1 CARTON (0245-1072-30) / 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE",
"package_ndc": "0245-1072-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20140411"
},
{
"sample": false,
"description": "1 BOTTLE in 1 CARTON (0245-1072-90) / 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE",
"package_ndc": "0245-1072-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20140411"
}
],
"productId": "0245-1072_5cfd7234-5efc-4cb8-b69c-7e68b9f1a94f",
"useDomain": "unknown",
"dosageForm": "CAPSULE, EXTENDED RELEASE",
"productNdc": "0245-1072",
"deaSchedule": null,
"genericName": "Topiramate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TOPIRAMATE",
"strength": "50 mg/1"
}
],
"applicationNumber": "NDA205122",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20140411",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000008486",
"N0000185506",
"N0000182140"
],
"unii": [
"0H73WJJ391"
],
"rxcui": [
"1494766",
"1494769",
"1494771",
"1494775",
"1494778",
"1494781",
"1812419",
"1812421",
"1812425",
"1812427"
],
"spl_set_id": [
"46f54677-3a22-4c38-9b92-923020164e15"
],
"pharm_class_pe": [
"Decreased Central Nervous System Disorganized Electrical Activity [PE]"
],
"pharm_class_moa": [
"Cytochrome P450 3A4 Inducers [MoA]",
"Cytochrome P450 2C19 Inhibitors [MoA]"
],
"manufacturer_name": [
"Upsher-Smith Laboratories, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0245-1072_5cfd7234-5efc-4cb8-b69c-7e68b9f1a94f"